Burning Rock Biotech Files 6-K
Ticker: BNR · Form: 6-K · Filed: Jun 6, 2025 · CIK: 1792267
Sentiment: neutral
Topics: 6-K, reporting, foreign-private-issuer
TL;DR
Burning Rock Biotech filed a 6-K on 6/6/25, incorporating Exhibit 99.1 (excluding non-GAAP details).
AI Summary
Burning Rock Biotech Ltd. filed a Form 6-K on June 6, 2025, for the month of June 2025. The filing incorporates by reference Exhibit 99.1, excluding specific non-GAAP financial measure sections. The company is a foreign private issuer and files under the 1934 Act.
Why It Matters
This filing indicates ongoing reporting requirements for Burning Rock Biotech Ltd. as a foreign private issuer, providing updates to investors.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not appear to contain significant new financial or operational information.
Key Players & Entities
- Burning Rock Biotech Ltd (company) — Registrant
- 001-39316 (company) — SEC File Number
- June 6, 2025 (date) — Filing Date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, providing information that the registrant makes or is required to make public in its home country.
What specific exhibit is incorporated by reference in this filing?
Exhibit 99.1 is incorporated by reference.
Are there any exclusions from the incorporated exhibit?
Yes, the paragraphs under the heading 'Non-GAAP Measures,' the table under the heading 'Burning Rock Biotech Limited Reconciliations of GAAP and Non-GAAP Results,' and other discussions on non-GAAP measures are excluded.
What is the company's principal executive office address?
The address is No.5 Xingdao Ring Road North, International Bio Island, Guangzhou, Guangdong, People's Republic of China.
What is the company's SIC code?
The Standard Industrial Classification (SIC) code is 8071, which corresponds to SERVICES-MEDICAL LABORATORIES.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 6, 2025 regarding Burning Rock Biotech Ltd (BNR).